Biotype GmbH
General information
Biotype GmbH
Moritzburger Weg 67
01109 Dresden, Saxony
Germany
Contact person: Timm Zörgiebel, Chief Executive Officer
Company main phone: +49 (0351) 8838400
Website: http://www.biotype.de
Moritzburger Weg 67
01109 Dresden, Saxony
Germany
Contact person: Timm Zörgiebel, Chief Executive Officer
Company main phone: +49 (0351) 8838400
Website: http://www.biotype.de
| Year founded: | 1999 |
| Source of foundation: | Other |
| No. of employees: |
Worldwide: 90 At this location: 90 |
Corporate description / mission:
BIOTYPE is an innovative German solution provider for molecular precision diagnostics. BIOTYPE is committed to advancing precision medicine through our products and services for robust analysis and interpretation of clinical biomarkers.
BIOTYPE offers a strong portfolio of molecular cancer diagnostics for applications in hemato-oncology, liquid biopsy, and molecular profiling of solid tumors. The portfolio includes IVD assays for clinical diagnostics and RUO assays for translational and clinical research. In addition, BIOTYPE offers high-quality and IVD-compliant contract development and manufacturing services. BIOTYPE's proprietary MODAPLEX platform is a benchtop system for automated molecular profiling and multi-biomarker testing. MODAPLEX addresses the growing need to simplify and accelerate molecular precision testing by reliably delivering essential biomarker information required for decision-making in precision medicine. The MODAPLEX consolidates multigene testing into one workflow with same-day results.
BIOTYPE’s quality management system is certified according to ISO 9001 and ISO 13485.
BIOTYPE is an innovative German solution provider for molecular precision diagnostics. BIOTYPE is committed to advancing precision medicine through our products and services for robust analysis and interpretation of clinical biomarkers.
BIOTYPE offers a strong portfolio of molecular cancer diagnostics for applications in hemato-oncology, liquid biopsy, and molecular profiling of solid tumors. The portfolio includes IVD assays for clinical diagnostics and RUO assays for translational and clinical research. In addition, BIOTYPE offers high-quality and IVD-compliant contract development and manufacturing services. BIOTYPE's proprietary MODAPLEX platform is a benchtop system for automated molecular profiling and multi-biomarker testing. MODAPLEX addresses the growing need to simplify and accelerate molecular precision testing by reliably delivering essential biomarker information required for decision-making in precision medicine. The MODAPLEX consolidates multigene testing into one workflow with same-day results.
BIOTYPE’s quality management system is certified according to ISO 9001 and ISO 13485.
State of ownership: Private / independent
Headquarters: HQ: Yes
Headquarters: HQ: Yes
Categorization
| Sector: |
|
| Subsector: |
|
| Primary therapeutic areas: |
|
| Business model: |
|
| Customer segments: |
|
| Distribution: |
|
© 2026 Biotechgate by Venture Valuation